Table 2 |
||||
|
Comparative frequency of FCGR3B copy number variants with rheumatoid factor and anti-cyclic citrullinated peptide autoantibodies |
||||
|
FCGR3B CN |
Rheumatoid factor |
Anti-CCP |
||
|
|
||||
|
Positive |
Negative |
Positive |
Negative |
|
|
|
||||
|
< 2 |
19 (13.97%) |
5 (11.11%) |
7 (10.29%) |
5 (10.87%) |
|
2 |
106 (77.94%) |
33 (73.33%) |
52 (76.47%) |
36 (78.26%) |
|
> 2 |
11 (8.09%) |
7 (15.56%) |
9 (13.24%) |
5 (10.87%) |
|
Global test |
χ2 = 2.03, degrees of freedom = 2, P = 0.363 |
χ2 = 0.15, degrees of freedom = 2, P = 0.93 |
||
|
|
||||
|
Comparative frequency of Fc gamma receptor 3B (FCGR3B) copy number (CN) variants in rheumatoid arthritis patients positive and negative for rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) autoantibodies. Data presented as n (%). |
||||
|
Graf et al. Arthritis Research & Therapy 2012 14:R28 doi:10.1186/ar3731 |
||||
